• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管扩张症成人患者体内菌群组成的改变

Altered community compositions of in adults with bronchiectasis.

作者信息

Guan Wei-Jie, Yuan Jing-Jing, Li Hui-Min, Gao Yong-Hua, Chen Chun-Lan, Huang Yan, Chen Rong-Chang, Zhong Nan-Shan

机构信息

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China,

Sino-French Hoffmann Institute, Guangzhou Medical University, Guangzhou, People's Republic of China,

出版信息

Int J Chron Obstruct Pulmon Dis. 2018 Jul 17;13:2173-2182. doi: 10.2147/COPD.S159335. eCollection 2018.

DOI:10.2147/COPD.S159335
PMID:30140149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6054765/
Abstract

BACKGROUND

Bronchiectasis is a debilitating disease with chronic airway infection. , the dominant phylum, can be detected with high-throughput sequencing.

OBJECTIVE

To stratify compositions according to culture findings in bronchiectasis.

PATIENTS AND METHODS

We sampled sputum, split for culture and 16srRNA sequencing, from 106 patients with stable bronchiectasis and 17 healthy subjects. Paired sputa from 22 bronchiectasis patients were collected during exacerbations and convalescence.

RESULTS

Forty-five, 41, and 20 patients with clinically stable bronchiectasis had isolated (PA), other potentially pathogenic microorganisms, and commensals at the initial visit, respectively. The PA group (but not other groups) demonstrated significantly greater relative abundance of , and lower Shannon-Wiener Diversity Index, Simpson Diversity Index, and richness compared with healthy subjects. was the dominant genus that discriminated bronchiectasis patients (particularly in the PA group) from healthy subjects. Compared with baseline levels, community compositions in the PA group, but not in other groups, were more resilient during exacerbations and convalescence.

CONCLUSION

community compositions could be partially reflected by conventional sputum bacterial culture. Significantly altered community compositions - particularly, the increased relative abundance of and diminished community diversity - represent critical targets for novel interventions to restore normal airway microen-vironment in patients with bronchiectasis.

摘要

背景

支气管扩张症是一种伴有慢性气道感染的使人衰弱的疾病。通过高通量测序可以检测到作为优势菌门的[具体菌门名称未给出]。

目的

根据支气管扩张症的培养结果对[具体微生物名称未给出]菌群组成进行分层。

患者与方法

我们从106例稳定期支气管扩张症患者和17名健康受试者中采集痰液,将其分为用于培养和16srRNA测序的样本。在病情加重期和恢复期收集了22例支气管扩张症患者的配对痰液。

结果

在初次就诊时,45例、41例和20例临床稳定的支气管扩张症患者分别分离出[具体细菌名称未给出](PA)、其他潜在致病微生物和共生菌。与健康受试者相比,PA组(而非其他组)显示出[具体细菌名称未给出]的相对丰度显著更高,而香农 - 维纳多样性指数、辛普森多样性指数和丰富度更低。[具体细菌名称未给出]是区分支气管扩张症患者(特别是PA组)与健康受试者的优势菌属。与基线水平相比,PA组而非其他组的[具体微生物名称未给出]菌群组成在病情加重期和恢复期更具弹性。

结论

传统痰液细菌培养可部分反映[具体微生物名称未给出]菌群组成。显著改变的[具体微生物名称未给出]菌群组成——特别是[具体细菌名称未给出]相对丰度增加和菌群多样性降低——是恢复支气管扩张症患者气道微环境正常的新型干预措施的关键靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/57bca5b5cab7/copd-13-2173Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/677fa3f2cc92/copd-13-2173Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/c2eb235071dc/copd-13-2173Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/b1bfdac3bc32/copd-13-2173Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/57bca5b5cab7/copd-13-2173Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/677fa3f2cc92/copd-13-2173Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/c2eb235071dc/copd-13-2173Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/b1bfdac3bc32/copd-13-2173Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d893/6054765/57bca5b5cab7/copd-13-2173Fig4.jpg

相似文献

1
Altered community compositions of in adults with bronchiectasis.支气管扩张症成人患者体内菌群组成的改变
Int J Chron Obstruct Pulmon Dis. 2018 Jul 17;13:2173-2182. doi: 10.2147/COPD.S159335. eCollection 2018.
2
community compositions correlate with bronchiectasis severity.社区组成与支气管扩张症的严重程度相关。
Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1095-1105. doi: 10.5588/ijtld.18.0037.
3
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.支气管扩张症患者的痰微生物组与临床结局:一项前瞻性观察研究。
Lancet Respir Med. 2021 Aug;9(8):885-896. doi: 10.1016/S2213-2600(20)30557-9. Epub 2021 May 4.
4
A novel microbiota stratification system predicts future exacerbations in bronchiectasis.一种新的微生物组分层系统可预测支气管扩张症的未来恶化。
Ann Am Thorac Soc. 2014 May;11(4):496-503. doi: 10.1513/AnnalsATS.201310-335OC.
5
Sputum Exosomal microRNAs Profiling Reveals Critical Pathways Modulated By Colonization In Bronchiectasis.痰液外泌体微小RNA分析揭示支气管扩张症中定植所调节的关键通路
Int J Chron Obstruct Pulmon Dis. 2019 Nov 22;14:2563-2573. doi: 10.2147/COPD.S219821. eCollection 2019.
6
Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations.支气管扩张症加重期患者的炎症反应、肺功能测定及生活质量
Respir Care. 2015 Aug;60(8):1180-9. doi: 10.4187/respcare.04004. Epub 2015 Jun 9.
7
Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.临床稳定期和加重期支气管扩张症患者肺部微生物群的差异
PLoS One. 2017 Aug 22;12(8):e0183553. doi: 10.1371/journal.pone.0183553. eCollection 2017.
8
Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.支气管扩张症中抗铜绿假单胞菌IgG抗体与慢性气道感染
Respir Med. 2017 Jul;128:1-6. doi: 10.1016/j.rmed.2017.05.001. Epub 2017 May 2.
9
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.大环内酯类药物长期治疗对非囊性纤维化支气管扩张症患者呼吸微生物群组成的影响:来自随机、双盲、安慰剂对照 BLESS 试验的分析。
Lancet Respir Med. 2014 Dec;2(12):988-96. doi: 10.1016/S2213-2600(14)70213-9. Epub 2014 Oct 14.
10
genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis.基因型影响非 CF 支气管扩张症的肺功能、加重频率和气道微生物群。
Thorax. 2017 Apr;72(4):304-310. doi: 10.1136/thoraxjnl-2016-208775. Epub 2016 Aug 8.

引用本文的文献

1
Sputum Microbiota Compositions Correlate With Metabolome and Clinical Outcomes of COPD-Bronchiectasis Association: A Prospective Cohort Study.痰液微生物群组成与慢性阻塞性肺疾病-支气管扩张症关联的代谢组及临床结局相关:一项前瞻性队列研究。
Exploration (Beijing). 2025 May 4;5(4):e20240149. doi: 10.1002/EXP.20240149. eCollection 2025 Aug.
2
Infection and the microbiome in bronchiectasis.支气管扩张症中的感染和微生物组。
Eur Respir Rev. 2024 Jul 3;33(173). doi: 10.1183/16000617.0038-2024. Print 2024 Jul.
3
The human lung microbiome-A hidden link between microbes and human health and diseases.

本文引用的文献

1
Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients.比较 COPD 患者诱导痰和自然咳痰样本中的微生物群特征。
Respir Res. 2017 Aug 29;18(1):164. doi: 10.1186/s12931-017-0645-3.
2
Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.通过对非囊性纤维化支气管扩张症患者16S rRNA基因进行测序对痰液微生物组进行纵向评估。
PLoS One. 2017 Feb 7;12(2):e0170622. doi: 10.1371/journal.pone.0170622. eCollection 2017.
3
Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.
人类肺部微生物群——微生物与人类健康和疾病之间的隐藏联系。
Imeta. 2022 Jun 16;1(3):e33. doi: 10.1002/imt2.33. eCollection 2022 Sep.
4
Bacteria and viruses and clinical outcomes of asthma-bronchiectasis overlap syndrome: A cohort study.细菌、病毒与哮喘-支气管扩张重叠综合征的临床结局:一项队列研究。
Clin Transl Allergy. 2024 Jan;14(1):e12331. doi: 10.1002/clt2.12331.
5
Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis.支气管扩张症中以流感嗜血杆菌或铜绿假单胞菌为主的微生物亚型的气道差异抗性组及其与临床特征的相关性。
Respir Res. 2023 Nov 2;24(1):264. doi: 10.1186/s12931-023-02562-8.
6
Complex probiotics alleviate ampicillin-induced antibiotic-associated diarrhea in mice.复合益生菌可减轻氨苄西林诱导的小鼠抗生素相关性腹泻。
Front Microbiol. 2023 Apr 14;14:1156058. doi: 10.3389/fmicb.2023.1156058. eCollection 2023.
非囊性纤维化支气管扩张症中铜绿假单胞菌管理面临的挑战。
Respir Med. 2016 Aug;117:179-89. doi: 10.1016/j.rmed.2016.06.007. Epub 2016 Jun 7.
4
Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients.非囊性纤维化支气管扩张症患者社区获得性肺炎的微生物学和结局。
J Infect. 2015 Jul;71(1):28-36. doi: 10.1016/j.jinf.2015.03.009. Epub 2015 Apr 14.
5
Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China.中国广州稳定期支气管扩张症患者痰液细菌学研究
Int J Tuberc Lung Dis. 2015 May;19(5):610-9. doi: 10.5588/ijtld.14.0613.
6
Aetiology of bronchiectasis in Guangzhou, southern China.中国南方广州的支气管扩张病因。
Respirology. 2015 Jul;20(5):739-48. doi: 10.1111/resp.12528. Epub 2015 Mar 26.
7
Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.基质金属蛋白酶随非囊性纤维化支气管扩张症的气道微生物群组成和肺功能而变化。
Ann Am Thorac Soc. 2015 May;12(5):701-7. doi: 10.1513/AnnalsATS.201411-513OC.
8
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.大环内酯类药物长期治疗对非囊性纤维化支气管扩张症患者呼吸微生物群组成的影响:来自随机、双盲、安慰剂对照 BLESS 试验的分析。
Lancet Respir Med. 2014 Dec;2(12):988-96. doi: 10.1016/S2213-2600(14)70213-9. Epub 2014 Oct 14.
9
The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study.病毒感染在成人支气管扩张症肺部加重期的作用:一项前瞻性研究。
Chest. 2015 Jun;147(6):1635-1643. doi: 10.1378/chest.14-1961.
10
Predominant pathogen competition and core microbiota divergence in chronic airway infection.慢性气道感染中的主要病原体竞争和核心微生物群落差异。
ISME J. 2015 Jan;9(1):217-25. doi: 10.1038/ismej.2014.124. Epub 2014 Jul 18.